• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[微量服用麦角酸二乙酰胺(LSD):做法与风险]

[Microdosing LSD: practices and risks].

作者信息

Seragnoli Federico, Pires Martins Daniel, Thorens Gabriel

机构信息

Service d'addictologie, HUG, 1211 Genève 14.

出版信息

Rev Med Suisse. 2021 Jun 9;17(742):1108-1110.

PMID:34106534
Abstract

The practice of microdosing, which consists of ingesting a hallucinogen at 5-10% of a dose that would induce a psychedelic effect, has recently been the subject of growing interest by the media. The craze for microdosing has been relayed by the supposed effects of increased performance and creativity reported by professionals, especially in Silicon Valley. Despite this strong public interest, the evidence supporting this practice remains preliminary. Available studies are mostly based on single doses, leaving open the question of a possible stronger effect with regular doses. LSD's main effect is on the serotonin system, in particular on 5-HT2A receptors, a receptor involved in neurobiological processes underlying learning.

摘要

微剂量服用,即摄入能产生迷幻效果剂量5%-10%的致幻剂,这种做法近来受到媒体越来越多的关注。微剂量服用的热潮因专业人士,尤其是硅谷人士所报告的其能提高工作效率和创造力的假定效果而得到传播。尽管公众对此兴趣浓厚,但支持这种做法的证据仍属初步。现有研究大多基于单次剂量,常规剂量是否可能产生更强效果这一问题仍未解决。麦角酸二乙酰胺(LSD)的主要作用于血清素系统,尤其是5-HT2A受体,该受体参与学习背后的神经生物学过程。

相似文献

1
[Microdosing LSD: practices and risks].[微量服用麦角酸二乙酰胺(LSD):做法与风险]
Rev Med Suisse. 2021 Jun 9;17(742):1108-1110.
2
Changes in global and thalamic brain connectivity in LSD-induced altered states of consciousness are attributable to the 5-HT2A receptor.LSD 诱导的意识改变状态下全球和丘脑脑连接的变化归因于 5-HT2A 受体。
Elife. 2018 Oct 25;7:e35082. doi: 10.7554/eLife.35082.
3
Microdosing psychedelics: personality, mental health, and creativity differences in microdosers.微剂量使用迷幻剂:微剂量使用者的个性、心理健康和创造力差异。
Psychopharmacology (Berl). 2019 Feb;236(2):731-740. doi: 10.1007/s00213-018-5106-2. Epub 2019 Jan 2.
4
Microdosing psychedelics: Motivations, subjective effects and harm reduction.微剂量使用迷幻剂:动机、主观效应和减少危害。
Int J Drug Policy. 2020 Jan;75:102600. doi: 10.1016/j.drugpo.2019.11.008. Epub 2019 Nov 25.
5
Signaling snapshots of a serotonin receptor activated by the prototypical psychedelic LSD.血清素受体被典型迷幻剂 LSD 激活后的信号瞬时图像。
Neuron. 2022 Oct 5;110(19):3154-3167.e7. doi: 10.1016/j.neuron.2022.08.006. Epub 2022 Sep 9.
6
Crystal Structure of an LSD-Bound Human Serotonin Receptor.结合麦角酰二乙胺的人血清素受体的晶体结构
Cell. 2017 Jan 26;168(3):377-389.e12. doi: 10.1016/j.cell.2016.12.033.
7
A review of lysergic acid diethylamide (LSD) in the treatment of addictions: historical perspectives and future prospects.麦角酸二乙酰胺(LSD)用于成瘾治疗的综述:历史视角与未来前景。
Curr Drug Abuse Rev. 2014;7(3):146-56. doi: 10.2174/1874473708666150107120522.
8
Twenty percent better with 20 micrograms? A qualitative study of psychedelic microdosing self-rapports and discussions on YouTube.提高 20%?对迷幻药微剂量自我报告和 YouTube 讨论的定性研究。
Harm Reduct J. 2019 Nov 28;16(1):63. doi: 10.1186/s12954-019-0333-3.
9
Macrodosing to microdosing with psychedelics: Clinical, social, and cultural perspectives.迷幻药的大剂量到微剂量:临床、社会和文化视角。
Transcult Psychiatry. 2022 Oct;59(5):665-674. doi: 10.1177/13634615221119386. Epub 2022 Aug 29.
10
Potential safety, benefits, and influence of the placebo effect in microdosing psychedelic drugs: A systematic review.微量服用迷幻药物时安慰剂效应的潜在安全性、益处及影响:一项系统综述
Neurosci Biobehav Rev. 2020 Dec;119:194-203. doi: 10.1016/j.neubiorev.2020.09.035. Epub 2020 Oct 5.

引用本文的文献

1
Psychedelic-assisted therapy for palliative care within a home treatment setting: A case report.居家治疗环境中用于姑息治疗的迷幻剂辅助疗法:一例报告
Clin Case Rep. 2024 Aug 30;12(9):e9305. doi: 10.1002/ccr3.9305. eCollection 2024 Sep.
2
Can psychedelics enhance group psychotherapy? A discussion on the therapeutic factors.迷幻药能增强团体心理治疗吗?对治疗因素的探讨。
J Psychopharmacol. 2023 Jul;37(7):660-678. doi: 10.1177/02698811231155117. Epub 2023 Feb 28.